Skip to content

Author

Xihao Chang

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Jul 2026

Design, Synthesis, and Antifungal Activity of Novel Thiazole-2-carboxamide Derivatives Bearing Flexible Diaryl Linkers as Succinate Dehydrogenase Inhibitors.

To develop eco-friendly succinate dehydrogenase inhibitors with good fungicidal activity, various diaryl-substituted thiazole-2-carboxamide derivatives were designed and synthesized based on structure-activity relationships (SARs) and molecular docking. At 20 mg/L, most target compounds exhibited ≥80% inhibition against Valsa mali, Botrytis cinerea, Curvularia lunata, and Phytophthora capsici. Notably, compound G33 showed potent activity against B. cinerea (EC50 = 0.17 mg/L) and P. capsici (EC50 = 0.42 mg/L), outperforming commercial fungicides thifluzamide and boscalid. At 100 mg/L, G33 effectively suppressed B. cinerea infection on strawberries. Mechanistic studies revealed that G33 disrupted hyphal morphology and ultrastructure, compromised cell membrane integrity, dissipated mitochondrial membrane potential, and inhibited mycelial growth. Enzyme activity assays, molecular docking, and molecular dynamics (MD) simulations further confirmed that G33 directly targets succinate dehydrogenase. Combined with favorable theoretical calculation results and low toxicity, G33 emerges as a promising lead compound for developing highly efficient and environmentally benign agricultural fungicides.

Chao Zhang, Min Ge, Yuanjian Huang et al. · 0 citations
Jul 2026

Molecular Concatenation of 3,5-Dichloro-2,6-Difluoropyridin-4-amine with Heterocyclic Carboxylic Acids and Evaluation of their Antifungal Activity.

Succinate dehydrogenase (SDH) inhibitors face cross-resistance issues due to similar structures. To address this problem, we designed heterocyclic carboxamide derivatives based on a 3,5-dichloro-2,6-difluoropyridin-4-amine scaffold. Compounds A1 and A2 showed excellent antifungal activity against Rhizoctonia solani (EC50 = 1.08 and 1.18 mg/L), outperforming boscalid (EC50 = 1.82 mg/L). They also exhibited broad-spectrum activity against four pathogenic fungi. In vivo rice leaf tests confirmed good protective effects (A1 and A2 at 92.88% and 89.35%, respectively). Mechanistic studies revealed that A1 and A2 disrupt mycelial morphology (Scanning electron microscopy analysis and transmission electron microscopy analysis) and inhibit SDH, supported by molecular docking and enzyme activity assays. Importantly, acute oral toxicity to bees was low (LC50 > 500 mg/L), comparable to commercial fungicides. These results identify A1 and A2 as promising, bee-safe leads for next-generation SDHI fungicides.

Boyi Sun, Hui Wang, Dandan Wang et al. · 0 citations